Nadofaragene firadenovec
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Nadofaragene firadenovec, covering 2024-11-22 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer [Phase 3]